Androgens, cardiovascular risk factors and atherosclerosis
- 1 January 1998
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 148 references indexed in Scilit:
- Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI‐1) activity in lean women with and without the polycystic ovary syndromeClinical Endocrinology, 1996
- The relationship of natural androgens to coronary heart disease in males: a reviewAtherosclerosis, 1996
- Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged menThe American Journal of Cardiology, 1996
- Inhibition of cholesterylester accumulation by 17β-estradiol in macrophages through activation of neutral cholesterol esteraseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly menAtherosclerosis, 1996
- Up‐regulation of nitric oxide synthase by estradiol in human aorticendothelial cellsFEBS Letters, 1995
- Structure-specific inhibition of lysosomal cholesterol transport in macrophages by various steroidsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- A Prospective Study of Dehydroepiandrosterone Sulfate, Mortality, and Cardiovascular DiseaseNew England Journal of Medicine, 1986